If you are not able to view this e-mail properly, please click here to view it online
World Pharma Today Maqazine
World Pharma Today Linkedin Page World Pharma Today Facebook Page World Pharma Today Twitter Page Weekly Newsletter
Click here to subscribe to our Magazine
DIA Euromeeting 2017
Top Latest Press Releases
 Mettler Toledo at interpack 2017

Mettler Toledo Product Inspection demonstrates protection, productivity and quality at interpack 2017

Mettler-Toledo, a market leader in product inspection technology, will present a comprehensive range of solutions and upgradesat interpack 2017 for both the food and pharmaceutical sectors, as well as providing a wealth...


Interpack 2017: Bosch showcases comprehensive portfolio for solid pharmaceuticals New development for Continuous Manufacturing

At Interpack 2017, Bosch Packaging Technology presents its latest solutions for solid pharmaceuticals.According to Christian Treitel head of pharma business development...


Acura Pharmaceuticals and MainPointe Pharmaceuticals Announce Deal for Nexafed Products

Acura Pharmaceuticals, Inc. and MainPointe Pharmaceuticals, LLC announced that they have entered into a License Agreement to have MainPointe exclusively market NEXAFED and NEXAFED Sinus in the US and Canada.

ABITEC and IMCD Announce Specialty Lipid Distribution Agreement

ABITEC Corporation and IMCD Announce Specialty Lipid Distribution Agreement

US ingredients conglomerate announces new partnership to distribute specialty lipids into the pharmaceutical and nutritional markets in Asia and South America.


Thermo Fisher announces first-ever cloud-based application for connectivity to electronic pipettes

Life science researchers working across many applications can now benefit from the first-ever web-based pipetting application, developed to enable seamless connectivity with electronic pipettes...


Selvita Announces First Patient Dosed in Phase I/II Clinical Trial of SEL24 in Acute Myeloid Leukemia

Selvita announced that the first patient was dosed with SEL24 in a Phase I/II clinical trial, for acute myeloid leukemia (AML). SEL24 is a Selvita developed first-in-class dual PIM/FLT3...


For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2017 / Editorial Calender please click here


For the latest visit: www.worldpharmatoday.com

World Pharma Today